Gadolinium-primarily based contrast agents (GBCAs) are commonly Utilized in magnetic resonance imaging (MRI) to boost the visibility of blood vessels, tumors, inflammation, and other internal buildings. When frequently viewed as Safe and sound, considerations about GBCA toxicity have emerged over the past two decades—significantly in clients with